Brief: Johnson & Johnson Is Exploring Bid For Intra-Cellular Therapies - Bloomberg News
Jan 12 (Reuters) - Johnson & Johnson JNJ.N :
* JOHNSON & JOHNSON IS EXPLORING BID FOR INTRA-CELLULAR
THERAPIES
- BLOOMBERG NEWS
Source text: https://tinyurl.com/2ewjs83p
Further company coverage: JNJ.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Intra-Cellular Therapies
See all newsBrief: Intra-Cellular Therapies stockholder filed lawsuit against co, board in NY Supreme Court
Intra-Cellular Therapies Inc reports results for the quarter ended December 31 - Earnings Summary
U.S. RESEARCH ROUNDUP-Apple, Caterpillar, Visa
Street View: New drug launches, ITCI deal to boost J&J's growth
J&J beats quarterly sales and profit estimates on cancer drug sales (updated)